IgG positive n=32 IgG negative n=14
p value
Age (years) 47.5 ± 11.1 42.2 ± 13.8 0.172
Male, n (%) 23 (71.9) 9 (64.3) 0.427
Etiology of CKD Etiology of CKD Etiology of CKD Etiology of CKD
Diabetes Mellitus, n (%) 4 (12.5) 1 (7.1) 0.364
Glomerulonephritis, n (%) 7 (21.9) 1 (7.1)
Others, n (%) 21 (65.6) 12 (85.7)
Living donor, n (%) 24 (75.0) 11 (84.6) 0.392
Transplantation Duration (months) 108.9 ± 61.9 88.0 ± 78.8 0.337
Comorbidities Comorbidities Comorbidities Comorbidities
Diabetes, n (%) 10 (31.3) 3 (21.4) 0.381
Hypertension, n (%) 22 (68.8) 9 (64.3) 0.511
Coronary artery disease, n (%) 7 (21.9) 5 (35.7) 0.264
Chronic obstructive pulmonary disease, n (%) 2 (6.3) 1 (7.1) 0.673
BMI (kg/m²) 27.6 ± 4.3 26.9 ± 5.1 0.529
Serum creatinine (mg/dL) 1.33 (1.03-1.48) 1.15 (0.87-1.83) 0.867
e-GFR†(ml/min/1.73 m²) 63.5 ± 19.0 68.3 ± 33.6 0.537
Disease severity index Disease severity index Disease severity index Disease severity index
Asymptomatic to mild, n (%) 21 (66.0) 12 (85.0) 0.286
Severe to critical, n (%) 11 (34.0) 2 (15.0)
Days following RT-PCR test 37.5 (20.5-57.8) 82.5 (52.3-105.0) 0.001
Lowest white blood cell count, (/mm³) 4925.7 ± 1748.0 4596.8 ± 1667.2 0.582
Lowest lymphocytes count, (/mm³) 791.0 ± 603.0 665.4 ± 314.7 0.875
Peak CRP, (mg/dL) 75.8 ± 66.5 74.7 ± 58.0 0.813
Peak ferritin, (ng/mL) 625.0 (249.5-1468.3) 670.1 (236.0-1245.0) 0.839
Fibrinogen, (mg/dL) 447.8 (4.98-649.8) 329.1 (4.76-515.5) 0.439
Peak D- Dimer, (µg/mL) 1.03 (0.36-2.94) 0.91 (0.66-2.78) 0.868
Peak procalcitonin, (ng/mL) 1.72 (0.92-127.0) 92.5 (1.13-191.3) 0.146
Peak uric acid, (mg/dL) 8.1 ± 2.1 7.7 ± 2.3 0.622
Stopping MPA, n (%) 17 (53.1) 7 (50.0) 0.549
Stopping CNI, n (%) 3 (9.4) 0 (0.0) NA
Stopping MPA or CNI, n (%) 18 (56.3) 7 (50.0) 0.471